Amesite Operating Co Stock News

Amesite's Proprietary AI Powers Caregiver Solution Enables Contract Growth in Large Segments Amesite's Proprietary AI Powers Caregiver Solution Enables Contract Growth in Large Segments

Amesite's Hospice Documentation Addresses Key Pain in Market: Losses in Reimbursements Due to Deficient Documentation Amesite's Hospice Documentation Addresses Key Pain in Market: Losses in Reimbursements Due to Deficient Documentation

Automated Sales Process Has Successfully Enabled NurseMagic™ Enterprise Sales to Close within Hours of Enterprise Outreach Automated Sales Process Has Successfully Enabled NurseMagic™ Enterprise Sales to Close within Hours of Enterprise Outreach

DETROIT, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, will be at NASDAQ tomorrow with CEO Dr. Ann Marie Sastry for a media event to include appearing on the NASDAQ Tower in Times Square. NASDAQ is recognizing Amesite's recent progress in its business plan in launch...

DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference is taking place January 28-30, 2025, at the Borgata Hotel Sp...

DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions...

DETROIT, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the pricing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions...

DETROIT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a “best efforts” underwritten public offering. The proposed offering is subject to market ...